# Detection of False Positives From First-trimester Preeclampsia Screening (StopPRE) at the Second-trimester of Pregnancy

> **NCT03741179** · PHASE3 · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 974 (actual)

## Conditions studied

- Pre-Eclampsia

## Interventions

- **DRUG:** ASA-withdrawn group

## Key facts

- **NCT ID:** NCT03741179
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-20
- **Primary completion:** 2022-01-30
- **Final completion:** 2022-01-30
- **Target enrollment:** 974 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03741179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03741179, "Detection of False Positives From First-trimester Preeclampsia Screening (StopPRE) at the Second-trimester of Pregnancy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03741179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*